Synergistic Tissue Remodeling The GLOW protocol targets tissue remodeling from multiple angles simultaneously
Results usually take 24 weeks of consistent use, especially when combined with proper diet and exercise
In SURPASS 4 The risk of suffering from any major adverse cardiovascular event MACE-4 and MACE-3 (including myocardial infarction, stroke, hospitalization for angina, and all-cause death) with the highest dose of tirzepatide (15 mg per week) has been estimated at 050 (026095), which was intended to provide initial proof of the cardiovascular safety of tirzepatide [2, 5]
If you find yourself constantly worried about your readings, speak to your GP about managing health anxiety alongside blood pressure
A personalized assessment will help determine if GLP-1 is the right option for you based on your specific health conditions, medical history, and treatment goals
Lifestyle optimisation In line with NICE NG49, are dietary and physical activity interventions being maximised alongside any pharmacological approach